Hobbs GA, Der CJ, Rossman KL. RAS isoforms and mutations in cancer at a glance. J Cell Sci. 2016;129:1287–92.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Siegel RL, Miller KD, Wagle NS, Jemal A. Cancer statistics, 2023. CA Cancer J Clin. 2023;73:17–48.

Article  PubMed  Google Scholar 

Bryant KL, Mancias JD, Kimmelman AC, Der CJ. KRAS: feeding pancreatic cancer proliferation. Trends Biochem Sci. 2014;39:91–100.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Hingorani SR, Petricoin EF, Maitra A, Rajapakse V, King C, Jacobetz MA. Preinvasive and invasive ductal pancreatic cancer and its early detection in the mouse. Cancer Cell. 2003;4:437–450.

Article  CAS  PubMed  Google Scholar 

Collins MA, Bednar F, Zhang Y, Brisset J-C, Galbán S, Galbán CJ, et al. Oncogenic Kras is required for both the initiation and maintenance of pancreatic cancer in mice. J Clin Invest. 2012;122:639–53.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Storz P. Acinar cell plasticity and development of pancreatic ductal adenocarcinoma. Nat Rev Gastroenterol. 2017;14:296–304.

Article  CAS  Google Scholar 

Collado M, Gil J, Efeyan A, Guerra C, Schuhmacher AJ, Barradas M, et al. Senescence in premalignant tumours. Nature. 2005;436:642.

Article  CAS  PubMed  Google Scholar 

Sablina AA, Hector M, Colpaert N, Hahn WC. Identification of PP2A complexes and pathways involved in cell transformation. Cancer Res. 2010;70:10474–84.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Sangodkar J, Farrington CC, McClinch K, Galsky MD, Kastrinsky DB, Narla G. All roads lead to PP2A: exploiting the therapeutic potential of this phosphatase. FEBS J. 2016;283:1004–24.

Article  CAS  PubMed  Google Scholar 

Hydbring P, Larsson L-G. Cdk2: a key regulator of the senescence control function of Myc. Aging Albany 2010;2:244–50.

Article  CAS  Google Scholar 

Karnoub AE, Weinberg RA. Ras oncogenes: split personalities. Nat Rev Mol Cell Biol. 2008;9:517–31.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Letourneux C, Rocher G, Porteu F. B56-containing PP2A dephosphorylate ERK and their activity is controlled by the early gene IEX-1 and ERK. EMBO J. 2006;25:727–38.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Lin SS, Bassik MC, Suh H, Nishino M, Arroyo JD, Hahn WC, et al. PP2A regulates BCL-2 phosphorylation and proteasome-mediated degradation at the endoplasmic reticulum*. J Biol Chem. 2006;281:23003–12.

Article  CAS  PubMed  Google Scholar 

Farrell AS, Allen-Petersen B, Daniel CJ, Wang X, Wang Z, Rodriguez S, et al. Targeting inhibitors of the tumor suppressor PP2A for the treatment of pancreatic cancer. Mol Cancer Res. 2014;12:924–39.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Janghorban M, Langer EM, Wang X, Zachman D, Daniel CJ, Hooper J, et al. The tumor suppressor phosphatase PP2A-B56α regulates stemness and promotes the initiation of malignancies in a novel murine model. PLoS ONE. 2017;12:e0188910.

Article  PubMed  PubMed Central  Google Scholar 

Kauko O, Laajala TD, Jumppanen M, Hintsanen P, Suni V, Haapaniemi P, et al. Label-free quantitative phosphoproteomics with novel pairwise abundance normalization reveals synergistic RAS and CIP2A signaling. Sci Rep. 2015;5:13099.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Chang W-H, Liu Y, Hammes EA, Bryant KL, Cerione RA, Antonyak MA. Oncogenic RAS promotes MYC protein stability by upregulating the expression of the inhibitor of apoptosis protein family member Survivin. J Biol Chem. 2023;299:102842.

Article  CAS  PubMed  Google Scholar 

Wu Y, Gu T-T, Zheng P-S. CIP2A cooperates with H-Ras to promote epithelial–mesenchymal transition in cervical-cancer progression. Cancer Lett. 2015;356:646–55.

Article  CAS  PubMed  Google Scholar 

Arnold HK, Sears RC. Protein phosphatase 2A regulatory subunit B56α associates with c-Myc and negatively regulates c-Myc accumulation. Mol Cell Biol. 2006;26:2832–44.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Farrell AS, Sears RC. MYC Degradation. CSH Perspect Med. 2014;4:a014365.

Google Scholar 

Wang J, Okkeri J, Pavic K, Wang Z, Kauko O, Halonen T, et al. Oncoprotein CIP2A is stabilized via interaction with tumor suppressor PP2A/B56. EMBO Rep. 2017;18:437–50.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Sears R, Leone G, DeGregori J, Nevins JR. Ras enhances Myc protein stability. Mol Cell. 1999;3:169–79.

Article  CAS  PubMed  Google Scholar 

Seeling JM, Miller JR, Gil R, Moon RT, White R, Virshup DM. Regulation of β-Catenin signaling by the B56 subunit of protein phosphatase 2A. Science. 1999;283:2089–91.

Article  CAS  PubMed  Google Scholar 

Martinez AKF, Storz P. Mimicking and manipulating pancreatic acinar-to-ductal metaplasia in 3-dimensional cell culture. J Vis Exp. (144), e59096, https://doi.org/10.3791/59096 (2019).

Shi G, DiRenzo D, Qu C, Barney D, Miley D, Konieczny SF. Maintenance of acinar cell organization is critical to preventing Kras-induced acinar-ductal metaplasia. Oncogene. 2013;32:1950–8.

Article  CAS  PubMed  Google Scholar 

Tinsley SL, Allen-Petersen BL. PP2A and cancer epigenetics: a therapeutic opportunity waiting to happen. NAR Cancer. 2022;4:zcac002-.

Article  PubMed  PubMed Central  Google Scholar 

Muthalagu N, Monteverde T, Raffo-Iraolagoitia X, Wiesheu R, Whyte D, Hedley A, et al. Repression of the Type I interferon pathway underlies MYC- and KRAS-dependent evasion of NK and B cells in pancreatic ductal adenocarcinoma. Cancer Discov. 2020;10:872–87.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Aakula A, Sharma M, Tabaro F, Nätkin R, Kamila J, Honkanen H, et al. RAS and PP2A activities converge on epigenetic gene regulation. Life Sci Alliance. 2023;6:e202301928.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Vogt M, Stankovic ND, Garcia YC, Hofstetter J, Schneider K, Kuybu F. et al. Targeting MYC effector functions in pancreatic cancer by inhibiting the ATPase RUVBL1/2. Gut. 2024;73:1509–1528.

Article  PubMed  Google Scholar 

Thomas D, Radhakrishnan P. Tumor-stromal crosstalk in pancreatic cancer and tissue fibrosis. Mol Cancer. 2019;18.

Leonard D, Huang W, Izadmehr S, O'Connor CM, Wiredja DD, Wang Z. Selective PP2A enhancement through biased heterotrimer stabilization. Cell. 2020;181:688–701.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Kemp SB, Cheng N, Markosyan N, Sor R, Kim I-K, Hallin J, et al. Efficacy of a small molecule inhibitor of KrasG12D in immunocompetent models of pancreatic cancer. Cancer Discov. 2022;13:298–311.

Article  PubMed Central  Google Scholar 

Hingorani SR, Wang L, Multani AS, Combs C, Deramaudt TB, Hruban RH, et al. Trp53R172H and KrasG12D cooperate to promote chromosomal